I Krebs

931 total citations
11 papers, 576 citations indexed

About

I Krebs is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, I Krebs has authored 11 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 2 papers in Oncology. Recurrent topics in I Krebs's work include Glycosylation and Glycoproteins Research (5 papers), Cancer-related gene regulation (3 papers) and Galectins and Cancer Biology (3 papers). I Krebs is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Cancer-related gene regulation (3 papers) and Galectins and Cancer Biology (3 papers). I Krebs collaborates with scholars based in Germany, Denmark and United Kingdom. I Krebs's co-authors include Annemarie Poustka, Jan Mollenhauer, Uffe Holmskov, Stefan Wiemann, Stephan Herbertz, Jens Madsen, H.-J. Gröne, Herwart F. Otto, Burkhard Helmke and Adrian Merlo and has published in prestigious journals such as Blood, Oncogene and Human Molecular Genetics.

In The Last Decade

I Krebs

10 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Krebs Germany 9 287 155 101 95 84 11 576
Lene Udby Denmark 17 278 1.0× 157 1.0× 131 1.3× 80 0.8× 131 1.6× 25 829
Marcus Rothe Germany 9 338 1.2× 43 0.3× 72 0.7× 112 1.2× 65 0.8× 11 615
Anna Zhou United States 9 378 1.3× 248 1.6× 46 0.5× 159 1.7× 182 2.2× 26 873
J. J. Rinehart United States 13 154 0.5× 268 1.7× 88 0.9× 193 2.0× 113 1.3× 28 650
Chaya Moroz Israel 18 291 1.0× 285 1.8× 129 1.3× 115 1.2× 20 0.2× 45 728
Kumarasamypet M. Mohankumar India 14 378 1.3× 233 1.5× 69 0.7× 164 1.7× 39 0.5× 27 827
Awadh A. Binhazim United States 14 149 0.5× 70 0.5× 49 0.5× 59 0.6× 47 0.6× 23 444
Tiina Sepp United Kingdom 11 339 1.2× 251 1.6× 71 0.7× 83 0.9× 89 1.1× 15 1.2k
Yasuhiro Sugamata Japan 8 264 0.9× 178 1.1× 41 0.4× 111 1.2× 21 0.3× 8 583
Mary K. Short United States 13 330 1.1× 155 1.0× 119 1.2× 70 0.7× 16 0.2× 24 709

Countries citing papers authored by I Krebs

Since Specialization
Citations

This map shows the geographic impact of I Krebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Krebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Krebs more than expected).

Fields of papers citing papers by I Krebs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Krebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Krebs. The network helps show where I Krebs may publish in the future.

Co-authorship network of co-authors of I Krebs

This figure shows the co-authorship network connecting the top 25 collaborators of I Krebs. A scholar is included among the top collaborators of I Krebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Krebs. I Krebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Madsen, Jens, Ida Tornøe, Ole Nielsen, et al.. (2003). CRP‐ductin, the mouse homologue of gp‐340/deleted in malignant brain tumors 1 (DMBT1), binds gram‐positive and gram‐negative bacteria and interacts with lung surfactant protein D. European Journal of Immunology. 33(8). 2327–2336. 63 indexed citations
2.
Mollenhauer, Jan, Martin Deichmann, Burkhard Helmke, et al.. (2003). Frequent downregulation of DMBT1 and galectin‐3 in epithelial skin cancer. International Journal of Cancer. 105(2). 149–157. 41 indexed citations
3.
Mollenhauer, Jan, Hanna Müller, Stefan Lyer, et al.. (2002). The SRCR/SID region of DMBT1 defines a complex multi‐allele system representing the major basis for its variability in cancer. Genes Chromosomes and Cancer. 35(3). 242–255. 36 indexed citations
4.
Mollenhauer, Jan, Burkhard Helmke, Hanna Müller, et al.. (2002). Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes and Cancer. 35(2). 164–169. 53 indexed citations
5.
Mollenhauer, Jan, Burkhard Helmke, Hanna Müller, et al.. (2002). An integrative model on the role of DMBT1 in epithelial cancer. Cancer Detection and Prevention. 26(4). 266–274. 17 indexed citations
6.
Mollenhauer, Jan, Stephan Herbertz, Burkhard Helmke, et al.. (2001). Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer.. PubMed. 61(24). 8880–6. 80 indexed citations
7.
Mollenhauer, Jan, Stephan Herbertz, Uffe Holmskov, et al.. (2000). DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.. PubMed. 60(6). 1704–10. 153 indexed citations
8.
Mollenhauer, Jan, Uffe Holmskov, Stefan Wiemann, et al.. (1999). The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene. 18(46). 6233–6240. 72 indexed citations
9.
Krebs, I. (1997). Translocation breakpoint maps 5 kb 3' from TWIST in a patient affected with Saethre-Chotzen syndrome. Human Molecular Genetics. 6(7). 1079–1086. 53 indexed citations
10.
Ziegler-Heitbrock, HW, Reinhold Munker, E. Thiel, I Krebs, & G. Riethmüller. (1985). Killer cell activity of human monoblastic leukemia cells as detected with a monocyte-specific target cell. Blood. 65(1). 8–14. 8 indexed citations
11.
Krebs, I. (1976). Paul Natorps Ästhetik.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026